Karina Turakbaevna Umbetova

Karina Turakbaevna Umbetova

Auto-generated profile, based on publicly available information

Karina Turakbaevna Umbetova

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2020 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
PGP. V. Glybochko
P. V. Glybochko
VFV. V. Fomin
V. V. Fomin
SMS. V. Moiseev
S. V. Moiseev
SASergey Avdeev
Sergey Avdeev
AYA. G. Yavorovskiy
A. G. Yavorovskiy
ЯАЯковлева Александра Андреевна
Яковлева Александра Андреевна
Aim. In a retrospective study, we evaluated factors associated with the early development of septic shock in patients with severe COVID-19. Materials and methods. We collected medical records of the intensive care unit patients submitted by the local COVID-19 hospitals across Russia to the Federal Center for the Critical Care at the Sechenov First Moscow State Medical University (Sechenov University). Septic shock in crticially ill patients requiring mechanical ventilation was defined as a need in vasopressors to maintain blood pressure. Results. We studied 1078 patients with severe COVID-19 who were admitted to the intensive care units for respiratory support. There were 611 males and 467 females. The mean age was 61.013.7 years. Five hundred twenty five medical records (48.7%) were received from the Moscow hospitals, 159 (14.7%) from the Moscow region, and 394 (36.5%) from the hospitals located in 58 regions of the Russian Federation. In 613 (56.9%) patients, diagnosis of SARS-CoV-2 infection was confirmed by PCR, and in the other cases it was established on the basis of the clinical picture and the results of the chest CT scan. Septic shock developed in 214 (19.9%) of 1078 patients. In the logistic regression model, the risk of septic shock in patients older than 50 years was higher than in patients of a younger age (OR 2.34; 95% CI 1.533.67; p0.0001). In patients with more severe SARS-CoV-2 infection, there was an increase in the prevalence of cardiovascular diseases, including coronary heart disease and atrial fibrillation, type 2 diabetes and malignant tumors. The risk of septic shock in patients with three or more concomitant diseases was higher than in patients without any concomitant chronic diseases (OR 1.76; 95% CI 1.762.70). Conclusion. The risk of septic shock in patients with acute respiratory distress syndrome induced by SARS-CoV-2 is higher in patients older than 50 years with concomitant diseases, although a severe course of the disease is also possible in younger patients without any concomitant disorders.

1 January 2021 in IDCases
Verified
Journal Article
Open access
NKNina Karbysheva
Nina Karbysheva
MNMarina Nikonorova
Marina Nikonorova
OMOlga Matros
Olga Matros
IKIrina Kiushkina
Irina Kiushkina
ENElena Nemilostiva
Elena Nemilostiva
EVElena Volchkova
Elena Volchkova
• Opisthorchiasis is the main helminthiasis of Western Siberia. • The clinical picture of opisthorchiasis is non-specific. • One of the key signs of opisthorchiasis is hypereosinophilia.

1 October 2025 in Journal of Clinical Medicine Research
Verified
Journal Article
Open access
PDF file
ABAnna E. Bragina
Anna E. Bragina
ATAida Tarzimanova
Aida Tarzimanova
YRYulia Rodionova
Yulia Rodionova
KOKonstantin Osadchiy
Konstantin Osadchiy
TITatiana Ivanovna Ishina
Tatiana Ivanovna Ishina
VPValery Podzolkov
Valery Podzolkov
Background: Coronavirus disease 2019 (COVID-19) and obesity remain pressing global health concerns. Identifying predictors of severe disease is of particular importance. Pericardial fat tissue (PFT) is a known source of metainflammation due to its secretion of adipocytokines and inflammatory mediators. Moreover, cytokine storm plays a major role in COVID-19-related mortality. This study aimed to investigate the association between preexisting PFT volume and inflammatory markers in patients with COVID-19. Methods: The study included 290 hospitalized patients with confirmed COVID-19 infection. Based on PFT volume (above or below 3.45 cm3), patients were divided into two groups: with and without pericardial obesity (PO), consisting of 132 and 158 individuals, respectively. Clinical, laboratory, and imaging data were analyzed. Statistical analysis was performed in Statistica 12.0. Results: Significant intergroup differences were observed in the PO group for the following variables: male sex (P < 0.001), body mass index (BMI) (P < 0.001), obesity (P < 0.001), and history of diabetes mellitus (P = 0.003). No significant differences were found in lung computed tomography (CT) severity scores. However, patients with PO showed significantly lower oxygen saturation (SpO2) levels (P = 0.014) and a higher frequency of SpO2 ≤ 93% (P = 0.012). Ferritin levels were significantly higher in the PO group (median 440 (274.00 - 552.70) vs. 292.55 (156.00 - 521.50), P = 0.010). Linear correlation analysis revealed a positive association between PFT volume and age, BMI, glucose, ferritin, C-reactive protein, and D-dimer levels, and a negative correlation with oxygen saturation. Multivariate logistic regression confirmed an independent association between PFT volume and SpO2 ≤ 93%. Receiver operating characteristic (ROC) analysis identified a threshold PFT volume of 3.45 cm3 for predicting increased risk of severe COVID-19 (SpO2 ≤ 93%), with sensitivity of 66.7%, specificity of 65.0%, and area under the curve (AUC) of 0.710 (95% confidence interval (CI): 0.551 - 0.868, P < 0.001). Conclusions: Our data suggest that a PFT volume greater than 3.45 cm3 is a potential predictor of severe COVID-19.

11 December 2023 in Archives of Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
ATAnna Eduardovna Tsygankova
Anna Eduardovna Tsygankova
AGAndrey Gerasimov
Andrey Gerasimov
Vladimir ChulanovVladimir Chulanov
Vladimir Chulanov
ODOlga Valerievna Darvina
Olga Valerievna Darvina
KUKarina Turakbaevna Umbetova
Karina Turakbaevna Umbetova
EVElena Vasilevna Volchkova
Elena Vasilevna Volchkova
Background: Currently, the global HIV epidemic remains ongoing, with a significant number of patients having undiagnosed advanced HIV disease. Providing medical care to patients with both COVID-19 and advanced HIV disease presents specific challenges due to the simultaneous lung damage caused by the SARS-CoV-2 virus and opportunistic pathogens. Objectives: This study aimed to explain the rationale behind recommending HIV screening for patients with severe COVID-19. Methods: A single-center retrospective cohort study was conducted using electronic medical records from a specialized hospital in Moscow that focused on coinfection with HIV/COVID-19. Among the 3,563 patients hospitalized in the relevant departments during the study period, 408 patients were included based on the inclusion/exclusion criteria. Out of the 408 patients with both COVID-19 and advanced HIV disease, 132 individuals were newly diagnosed with HIV infection, while 276 individuals had a previously established HIV diagnosis. Results: The mortality rate in the group of patients with COVID-19 and advanced HIV disease was 31.7% (95% CI, 27.3 - 36.3%). Among patients with COVID-19 and newly diagnosed advanced HIV disease, the mortality rate was 45.5% (95% CI, 37.1 - 54%), while in the group of patients with previously diagnosed advanced HIV disease, the mortality rate was 25% (95% CI, 20.2 - 30.4%). The proportion of individuals with critical CT-4 lung disease in the first group was 32.3% compared to 9.4% in the second group (P < 0.001). The median CD4+ count was 20 cells/µL in the first group compared with 88 cells/µL in the second group (P < 0.001). Conclusions: The presence of pneumocystis pneumonia increased the risk of death by 2.51 times in patients with COVID-19 and newly diagnosed advanced HIV disease. Additionally, Kaposi's sarcoma increased the risk of death by 1.31 times in the same patient group. Furthermore, the detection of HIV infection for the first time during hospitalization due to COVID-19 in the entire study cohort increased the risk of death by 2.21 times.

7 October 2018 in Journal Infectology
Verified
Journal Article
Open access
PDF file
DAD. D. Arutyunova
D. D. Arutyunova
KUK. T. Umbetova
K. T. Umbetova
YPYu. G. Parchomenko
Yu. G. Parchomenko
OTO. A. Tishkevich
O. A. Tishkevich
EVE. V. Volchkova
E. V. Volchkova
SPS. G. Pak
S. G. Pak
Развитие мезентериального лимфаденита характерно для больных ВИЧ-инфекцией на стадии вторичных заболеваний. Целью нашего исследования явилась расшифровка этиологии лимфаденита у больных ВИЧинфекцией на стадии вторичных заболеваний. Проведен анализ историй болезней 113 больных ВИЧ-инфекцией на стадии вторичных заболеваний с применением статистической обработки. В статье представлены примеры, характеризующие полиморфизм клинических вариантов развития мезаденита у ВИЧ-инфицированных пациентов на стадии 4В, развившегося в результате воздействия различных этиологических факторов.

15 February 2020 in Epidemiology and Infectious Diseases
Verified
Journal Article
Open access
PDF file
MBMarina N. Bojchenko
Marina N. Bojchenko
EKElena O. Kravtsova
Elena O. Kravtsova
EBElena Budanova
Elena Budanova
OBOlga F. Belaia
Olga F. Belaia
NMNatalya V. Maloletneva
Natalya V. Maloletneva
KUKarina T. Umbetova
Karina T. Umbetova
Bacterial vacuolated intracellular parasites, such as Salmonella spp. and Brucella spp., possess the ability to cause persistent, long-life chronic infection during which the microbe continues to replicate inside the host organism in spite of the development of an immune response. Such bacteria develop a strategy to evade the immune response, which plays a key role in the development of chronic infection. The implementation of this strategy is aimed at inhibiting the action of factors of innate immunity. In brucella, this process is mediated by the noncanonical structure of lipopolysaccharide (LPS), as a result of which the pathogen is not recognized by the cells of innate immunity, as well as by the functioning of T4CC, the effector proteins of which block the development of the inflammatory response. The strategy of S. Typhi is realized via the expression of genes of pathogenicity island 7 encoding Vi-antigen and genotoxin. Vi-antigen inhibits recognition of the microbe by cells of the innate immune system. Typhoid genotoxin causes the death of immune cells. Brucella realizes this strategy via the noncanonical structure of LPS and T4SS, effector proteins of which block the development of inflammation. Alternative activated macrophages appear during chronic infection caused by both pathogens. These microbes are able to regulate the metabolism of macrophages according to their needs while persisting in them. A review of the sources of information on this problem allows us to conclude that both the causative agent of typhoid fever S. Typhi and the causative agents of brucellosis use the same strategies for the development of a chronic infectious process, but the implementation of these strategies is carried out specifically.